Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe sponsor line for the MOR106 study was updated to Lakefront Biotherapeutics NV, and Galapagos NV was removed, indicating a shift in the organization responsible for the trial.SummaryDifference0.1%

- Check17 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer version of the page template or documentation being used.SummaryDifference0.0%

- Check25 days agoChange DetectedNo changes were detected in the provided content; the page content remains unchanged.SummaryDifference0.0%

- Check32 days agoChange DetectedNo changes were detected for this page based on the provided data. The page content remains unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page footer was updated to a newer ClinicalTrials.gov site revision (from v3.5.0 to v3.5.3).SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page's version history.SummaryDifference0.0%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.